Erratum to: Breast Cancer Res Treat (2014) 144: 635–642 DOI 10.1007/s10549-014-2894-x
Unfortunately, in the original publication of the article, the BRCA1 mutation 1966ins7 listed in Table 3 was erroneously published as one of the deleterious mutations identified in Singaporean carriers. The correct mutation should read as 1966delC, with the corresponding HGVS (c.1847_1847delC) and amino acid change (STOP 625). The authors would like to rectify this with the publication of corrected Table 3 as given below. In addition, STOP 626 was reported in error in the published article as the corresponding amino acid change for BRCA1 c.1847delC mutation. The correct amino acid change for this mutation should read as STOP 625. The authors also noted errors in the citation listed on Online Resource 1A and 1B. The authors would like to correct this with the publication of corrected Online Resource 1A and 1B.
Author information
Authors and Affiliations
Corresponding author
Additional information
Peter Choon Eng Kang, Sze Yee Phuah, Kavitta Sivanandan, In Nee Kang joint first authors.
The online version of the original article can be found under doi:10.1007/s10549-014-2894-x.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kang, P.C.E., Phuah, S.Y., Sivanandan, K. et al. Erratum to: Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history. Breast Cancer Res Treat 150, 699–700 (2015). https://doi.org/10.1007/s10549-015-3360-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-015-3360-0